Results 41 to 50 of about 3,130,322 (229)

Ovarian Carcinoma - A Single Centre Case-Series Descriptive Analysis of Surgical Procedures.

Chirurgia
Background: Ovarian surface epithelial cancer (OSEC) are an entity in which, according to genomics and pathology data accumulated in the last couple of decades, several different nosological entities with distinct etiologies are aggregated.
George Daniel Subtirelu, Andreea Steriu, Eugen Brătucu   +2 more
semanticscholar   +1 more source

When should surgical cytoreduction in advanced ovarian cancer take place? [PDF]

, 2010
Initial surgical management is commonly accepted to date as paramount in the treatment of women presenting with epithelial ovarian cancer and permits the assessment of the disease (staging), the histological confirmation of disease type and grade, and ...
Kehoe, Sean, Martinek, Igor E
core   +1 more source

Neoadjuvant chemotherapy followed by surgical cytoreduction in advanced epithelial ovarian cancer [PDF]

, 2006
AIMS: To study the role of neoadjuvant chemotherapy (NACT) followed by surgical cytoreduction in the management of advanced epithelial ovarian cancers.
Deo SVS, Goyal Hemant, Shukla NK, Raina V, Kumar Lalit, Srinivas G
core   +3 more sources

Does the Performance of Splenectomy as Part of Cytoreductive Surgery Carry a Worse Prognosis Than in Patients Not Receiving Splenectomy? A Propensity Score Analysis and Review of the Literature

Journal of Investigative Surgery, 2022
Background & Objectives Ultra-radical (UR) procedures, including splenectomy, are utilized to increase complete cytoreduction rates during Cytoreductive Surgery (CRS) performed with the aim of complete macroscopic clearance of disease.
James Davies, Viren Asher, Anish Bali, Summi Abdul, Andrew Phillips   +4 more
doaj   +1 more source

Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases

Annals of Surgical Oncology, 2016
PurposeThe aim of this study was to help with the process of selecting patients with advanced ovarian cancer to undergo cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) by analyzing outcome data at distinct clinical time
A. Di Giorgio, P. De Iaco, M. De Simone, A. Garofalo, G. Scambia, A. Pinna, G. Verdecchia, L. Ansaloni, A. Macrì, P. Cappellini, V. Ceriani, G. Giorda, D. Biacchi, M. Vaira, M. Valle, P. Sammartino   +15 more
semanticscholar   +1 more source

Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer

, 2010
Background: Despite radical surgical and chemotherapeutic treatment of ovarian cancer, the majority of patients develop recurrent disease. Secondary cytoreductive surgery can result in favourable outcome in selected patients, but information regarding ...
Woelber, L., Jaenicke, F., Schwarz, J., Jung, S., Mahner, S., Mueller, V., Eulenburg, C., S. Jung, V. Mueller, C. Eulenburg, S. Mahner, F. Jaenicke, L. Woelber, J. Schwarz   +13 more
core   +1 more source

Experience with the use of HIPEC in advanced serous ovarian cancer after complete and optimal cytoreduction.

Experimental oncology, 2021
BACKGROUND Ovarian cancer (OC) is one of the most demanding unresolved issues in oncogynecology. In Ukraine, there are over 3000 new cases of the disease annually. 24.6% of patients die within the first year after diagnosis. It indicates the relevance of
N. Tsip, V. Kopetskiy, Y. O. Polentsov, M. Yegorov, G. Vakulenko, V. Svintsitskiy   +5 more
semanticscholar   +1 more source

Hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma after cytoreductive surgical procedures: a systematic review

World Journal of Surgical Oncology
Abstract Surgery-based multimodality therapies for treatment of malignant pleural mesothelioma have been clinically explored in the past decades. In this regard, hyperthermic intrathoracic or intrapleural chemotherapy has been used as one of the multimodality therapies.
Hany Hasan Elsayed, Mohamed Elanany Elsaid Elanany, Mohamed Tarek ElSayegh, Aly Sherif Hassaballa, Mohammed Abdel-gayed   +4 more
openaire   +3 more sources

Comparison of coagulation parameters associated with fibrinogen concentrate and cryoprecipitate for treatment of bleeding in patients undergoing cytoreductive surgery for pseudomyxoma peritonei: Subanalysis from a randomized, controlled phase 2 study

Health Science Reports, 2023
Background and Aims The FORMA‐05 study compared the efficacy and safety of human fibrinogen concentrate (HFC) versus cryoprecipitate for hemostasis in bleeding patients undergoing cytoreductive surgery for pseudomyxoma peritonei (PMP).
Ashok Roy, Nigel Sargant, John Bell, Sophia Stanford, Cristina Solomon, Irina Kruzhkova, Sigurd Knaub, Faheez Mohamed   +7 more
doaj   +1 more source

Morbidity and Mortality of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients Aged 70 Years and Older: A Two‐Center 10‐Year Experience

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is established for peritoneal surface malignancies, but its use in older patients is debated. We assessed CRS‐HIPEC morbidity and mortality in patients aged ≥ 70 years using a cohort of younger patients as a comparator.
Ali Ediz Kıvanç, Mehmet Oduncu, Pırıltı Özcan, Özgül Düzgün, Neşet Köksal   +4 more
wiley   +1 more source